Floatz logo

296 assets in Myelodysplastic Syndrome

Therapeutic assets addressing Myelodysplastic Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
mt-401-ots
Myelodysplastic Syndrome
Marker Therapeutics, Inc.P1CC (41)
nkx101 - car nk cell therapy
Myelodysplastic Syndrome
Nkarta, Inc.P1CC (41)
qh101
Myelodysplastic Syndrome
Anhui Provincial HospitalP1CC (41)
rp7214
Myelodysplastic Syndrome
Rhizen Pharmaceuticals SAP1/2CC (41)
sar443579
Myelodysplastic Syndrome
SanofiP1/2CC (41)
Sonrotoclax
Myelodysplastic Syndrome
BeiGeneP1/2CC (41)
Tagraxofusp
Myelodysplastic Syndrome
Therapeutic Advances in Childhood Leukemia ConsortiumP1CC (41)
Tgrx-814
Myelodysplastic Syndrome
Shenzhen TargetRx Co., Ltd.P1/2CC (41)
tqb3454
Myelodysplastic Syndrome
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P1/2CC (41)
vor33
Myelodysplastic Syndrome
Vor BiopharmaP1/2CC (41)
Xzb-0004
Myelodysplastic Syndrome
Xuanzhu Biopharmaceutical Co., Ltd.P1CC (41)
Zilurgisertib
Myelodysplastic Syndrome
Incyte CorporationP1/2CC (41)
Donor T Cells
Myelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2CC (40)
Jnj-64619178
Myelodysplastic Syndrome
Janssen Research & Development, LLCP1CC (40)
Jnj-74856665
Myelodysplastic Syndrome
Janssen Research & Development, LLCP1CC (40)
Actinium Ac 225-Dota-Daratumumab
Myelodysplastic Syndrome
City of Hope Medical CenterP1C (39)
Allodepleted T Cells
Myelodysplastic Syndrome
Baylor College of MedicineP1C (39)
Autologous Car123 T Lymphocytes
Myelodysplastic Syndrome
Institute of Hematology and Blood Transfusion, Czech RepublicEarly P1C (39)
Btx-A51
Myelodysplastic Syndrome
Edgewood Oncology Inc.P1C (39)
Camibirstat
Myelodysplastic Syndrome
Montefiore Medical CenterP1C (39)
Camidanlumab Tesirine
Myelodysplastic Syndrome
Gwynn Long, M.D.P2C (39)
CD64 CAR T Cells
Myelodysplastic Syndrome
University of Colorado, DenverP1C (39)
Cirtuvivint
Myelodysplastic Syndrome
National Cancer Institute (NCI)P1C (39)
Cyad-02
Myelodysplastic Syndrome
Celyad Oncology SAP1C (39)
Decoy-Resistant Interleukin-18
Myelodysplastic Syndrome
Fred Hutchinson Cancer CenterP1C (39)
Emapalumab
Myelodysplastic Syndrome
City of Hope Medical CenterP1C (39)
Endoxan
Myelodysplastic Syndrome
Celyad Oncology SAP1C (39)
Everolimus
Myelodysplastic Syndrome
OHSU Knight Cancer InstituteP1C (39)
Exercise Mobilized Prophylactic Dli
Myelodysplastic Syndrome
University of ArizonaP1C (39)
Hyaluronidase Fihj
Myelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsEarly P1C (39)
Icaspase9-Transduced T Cells
Myelodysplastic Syndrome
Baylor College of MedicineP1C (39)
Imgn632
Myelodysplastic Syndrome
Fred Hutchinson Cancer CenterP1C (39)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Myelodysplastic Syndrome
Mayo ClinicP1C (39)
Indium In 111-Dota-Basiliximab
Myelodysplastic Syndrome
City of Hope Medical CenterP1C (39)
Indium In 111-Dota-Daratumumab
Myelodysplastic Syndrome
City of Hope Medical CenterP1C (39)
Orm-6151
Myelodysplastic Syndrome
Bristol-Myers SquibbP1C (39)
Partially Engineered T-Regulatory Cell Donor Graft Trgft-201
Myelodysplastic Syndrome
City of Hope Medical CenterP1C (39)
PRT1419
Myelodysplastic Syndrome
Prelude TherapeuticsP1C (39)
Quail-100
Myelodysplastic Syndrome
Laguna Biotherapeutics, Inc.P1C (39)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Myelodysplastic Syndrome
Mayo ClinicP1C (39)
Rezatapopt
Myelodysplastic Syndrome
M.D. Anderson Cancer CenterP1C (39)
RPT1G
Myelodysplastic Syndrome
Remedy Plan, Inc.P1C (39)
Sea-Cd70
Myelodysplastic Syndrome
Seagen, a wholly owned subsidiary of PfizerP1C (39)
Taa-Specific Ctls
Myelodysplastic Syndrome
Baylor College of MedicineP1C (39)
Vic-1911
Myelodysplastic Syndrome
Masonic Cancer Center, University of MinnesotaP1/2C (39)
xs-04
Myelodysplastic Syndrome
NovaOnco Therapeutics Co., Ltd.P1C (39)
Yttrium Y 90 Basiliximab
Myelodysplastic Syndrome
City of Hope Medical CenterP1C (39)
Anzurstobart
Myelodysplastic Syndrome
Bristol-Myers SquibbP1C (37)
Arc-T Cells
Myelodysplastic Syndrome
Arcellx, Inc.P1C (37)
aur103
Myelodysplastic Syndrome
Aurigene Discovery Technologies LimitedP1C (37)
Showing 201 to 250 of 296 assets
PreviousPage 5 of 6Next